Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

Media coverage

• Title	Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
  Media name/outlet	Metro - News Channel Nebraska
  Country/Territory	United States
  Date	7/07/25
  URL	metro.newschannelnebraska.com/story/52903503/cogent-biosciences-announces-positive-top-line-results-achieving-statistical-significance-across-all-primary-and-key-secondary-endpoints-from-the
  Persons	Nathan Boggs